From Brazilian Innovation to the Global Market: Cardios in Kenya

Cardios is proud to announce a significant milestone in its journey: our successful participation in WHX Nairobi 2025, one of the most important events in the healthcare sector on the African continent, held in Kenya.

This event represented a unique opportunity to demonstrate how the diagnostic precision developed in Brazil can transform cardiology in different global contexts.

Presenting Cutting-Edge Solutions in Africa

Our representatives, Paulo Eduardo Vinovich and Paulo Henrique Sieler, led the presentation of Cardios solutions for the demanding African market. The focus was on our advanced cardiac monitoring technologies and M.A.P.A. (Ambulatory Blood Pressure Monitoring).

More than just showcasing equipment, our team demonstrated the real impact that diagnostic precision has on the prevention and treatment of cardiovascular diseases, adapting our expertise to the specific health needs in Kenya and neighboring countries.

A Robust Internationalization Strategy

Participation in WHX Nairobi 2025 is not an isolated event; it is a calculated step in our internationalization strategy. This advancement is made possible through a fundamental partnership with ABIMO (Brazilian Association of Medical Device Industries) and APEX Brazil (Brazilian Trade and Investment Promotion Agency).

The support of these entities is vital, as they assist Brazilian exporting companies, such as Cardios, in prospecting and expanding international markets, ensuring that our technology reaches those who need it most, wherever they are.

Essential Connections for the Future

For the success of a global initiative, local support is indispensable. We are deeply grateful for the support from the Brazilian Embassy in Kenya. The embassy has acted as an essential bridge, facilitating the establishment of local connections and helping us understand in depth the needs and regulations of the African healthcare market.

Cardios sees this participation as the beginning of a lasting and promising relationship with the African continent, reinforcing our commitment to bringing excellence and innovation in cardiology to the world.